Eva Johanna Schaefer, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hemoglobinuria, Paroxysmal | 1 | 2018 | 86 | 0.560 |
Why?
|
| Bone Marrow Diseases | 1 | 2018 | 234 | 0.520 |
Why?
|
| Anemia, Aplastic | 1 | 2018 | 231 | 0.510 |
Why?
|
| Leukemia | 1 | 2022 | 1522 | 0.430 |
Why?
|
| Leukemia, Myeloid, Acute | 4 | 2024 | 3640 | 0.420 |
Why?
|
| Sulfonamides | 3 | 2024 | 1981 | 0.340 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2018 | 1403 | 0.290 |
Why?
|
| Altitude | 1 | 2023 | 162 | 0.200 |
Why?
|
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2023 | 230 | 0.190 |
Why?
|
| Shock | 1 | 2021 | 316 | 0.150 |
Why?
|
| Multiple Trauma | 1 | 2021 | 369 | 0.150 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2024 | 954 | 0.140 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2018 | 18061 | 0.130 |
Why?
|
| Neoplasms, Second Primary | 1 | 2024 | 1048 | 0.130 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 3 | 2024 | 11865 | 0.120 |
Why?
|
| Mutation | 3 | 2024 | 30184 | 0.120 |
Why?
|
| Repressor Proteins | 1 | 2022 | 2968 | 0.090 |
Why?
|
| Cell Cycle Proteins | 1 | 2022 | 3431 | 0.090 |
Why?
|
| Chromatin | 1 | 2022 | 2981 | 0.080 |
Why?
|
| Nuclear Proteins | 1 | 2024 | 5781 | 0.080 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2022 | 4520 | 0.080 |
Why?
|
| Blood Glucose | 1 | 2023 | 6427 | 0.080 |
Why?
|
| Epigenesis, Genetic | 1 | 2022 | 3818 | 0.080 |
Why?
|
| Daunorubicin | 1 | 2024 | 157 | 0.050 |
Why?
|
| Cytarabine | 1 | 2024 | 697 | 0.050 |
Why?
|
| C-Peptide | 1 | 2023 | 443 | 0.050 |
Why?
|
| Inflammation | 1 | 2021 | 10846 | 0.050 |
Why?
|
| Peru | 1 | 2023 | 887 | 0.040 |
Why?
|
| Signal Transduction | 1 | 2022 | 23589 | 0.040 |
Why?
|
| Protein Isoforms | 1 | 2023 | 1718 | 0.040 |
Why?
|
| Biodiversity | 1 | 2021 | 344 | 0.040 |
Why?
|
| Metagenomics | 1 | 2021 | 473 | 0.030 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2021 | 1043 | 0.030 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2024 | 1761 | 0.030 |
Why?
|
| Hydrocortisone | 1 | 2023 | 1832 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2023 | 2036 | 0.030 |
Why?
|
| Neoplasms | 1 | 2023 | 22345 | 0.030 |
Why?
|
| Humans | 7 | 2024 | 765734 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2021 | 3805 | 0.030 |
Why?
|
| ROC Curve | 1 | 2021 | 3618 | 0.030 |
Why?
|
| Glucose | 1 | 2023 | 4334 | 0.020 |
Why?
|
| Genomics | 1 | 2023 | 5924 | 0.020 |
Why?
|
| Retrospective Studies | 2 | 2024 | 81457 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2021 | 18289 | 0.010 |
Why?
|
| Aged | 2 | 2024 | 171050 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2024 | 41631 | 0.010 |
Why?
|
| Male | 3 | 2024 | 363585 | 0.010 |
Why?
|
| Middle Aged | 2 | 2024 | 222903 | 0.010 |
Why?
|
| Adult | 2 | 2024 | 222974 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2024 | 59459 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2024 | 65180 | 0.010 |
Why?
|
| Female | 2 | 2024 | 395961 | 0.010 |
Why?
|
| Mice | 1 | 2021 | 81792 | 0.010 |
Why?
|
| Animals | 1 | 2021 | 168731 | 0.000 |
Why?
|